Ashley E Kelly, CRNA | |
506 6th Street, Ny Methodist Hospital, Brooklyn, NY 11215 | |
(718) 780-3279 | |
Not Available |
Full Name | Ashley E Kelly |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 17 Years |
Location | 506 6th Street, Brooklyn, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306014774 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 593835-1 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
Advocate Lutheran General Hospital | Park ridge, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore University Healthsystem Faculty Practice Associates | 2163334699 | 1751 |
Mobile Anesthesiologists Chicago Pllc | 9436119542 | 50 |
News Archive
The new platform uses cell-free synthetic biology to test for 17 contaminants, including lead, copper, pharmaceuticals and cosmetics.
The Economist examines how "the past decade has seen changes in how vaccines are developed, financed and delivered - solving, at least partially, the conundrum of the vaccine market: poor regions have ample demand for vaccines but little ability to pay for them. As a result, immunisation rates in the poor world have soared."
A trial of beta-interferon-1a in inclusion-body myositis (IBM) has failed to find benefit from the drug in this disease. Beta-interferons counteract some of the activities of the immune system, which some experts believe is misguided in IBM.
A natural products chemistry company has licensed the rights for a promising botanical compound from the University of Mississippi and the Agricultural Research Service, which is the principal intramural scientific research agency of the U.S. Department of Agriculture.
The drug, mitomycin C (MMC), is a well-known anticancer treatment used mainly against solid tumours in the bladder and lower bowel. It is activated by enzymes naturally found in the human body, but its use is limited by severe side effects at higher doses.
› Verified 7 days ago
Entity Name | Northshore University Healthsystem Faculty Practice Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
The new platform uses cell-free synthetic biology to test for 17 contaminants, including lead, copper, pharmaceuticals and cosmetics.
The Economist examines how "the past decade has seen changes in how vaccines are developed, financed and delivered - solving, at least partially, the conundrum of the vaccine market: poor regions have ample demand for vaccines but little ability to pay for them. As a result, immunisation rates in the poor world have soared."
A trial of beta-interferon-1a in inclusion-body myositis (IBM) has failed to find benefit from the drug in this disease. Beta-interferons counteract some of the activities of the immune system, which some experts believe is misguided in IBM.
A natural products chemistry company has licensed the rights for a promising botanical compound from the University of Mississippi and the Agricultural Research Service, which is the principal intramural scientific research agency of the U.S. Department of Agriculture.
The drug, mitomycin C (MMC), is a well-known anticancer treatment used mainly against solid tumours in the bladder and lower bowel. It is activated by enzymes naturally found in the human body, but its use is limited by severe side effects at higher doses.
› Verified 7 days ago
Entity Name | Mobile Anesthesiologists Chicago Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396887774 PECOS PAC ID: 9436119542 Enrollment ID: O20041013000867 |
News Archive
The new platform uses cell-free synthetic biology to test for 17 contaminants, including lead, copper, pharmaceuticals and cosmetics.
The Economist examines how "the past decade has seen changes in how vaccines are developed, financed and delivered - solving, at least partially, the conundrum of the vaccine market: poor regions have ample demand for vaccines but little ability to pay for them. As a result, immunisation rates in the poor world have soared."
A trial of beta-interferon-1a in inclusion-body myositis (IBM) has failed to find benefit from the drug in this disease. Beta-interferons counteract some of the activities of the immune system, which some experts believe is misguided in IBM.
A natural products chemistry company has licensed the rights for a promising botanical compound from the University of Mississippi and the Agricultural Research Service, which is the principal intramural scientific research agency of the U.S. Department of Agriculture.
The drug, mitomycin C (MMC), is a well-known anticancer treatment used mainly against solid tumours in the bladder and lower bowel. It is activated by enzymes naturally found in the human body, but its use is limited by severe side effects at higher doses.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Ashley E Kelly, CRNA P.o. Box 550, 2 Catharine Street Park Slope Anesthesia Associates, Pc, Poughkeepsie, NY 12600 Ph: (845) 790-2661 | Ashley E Kelly, CRNA 506 6th Street, Ny Methodist Hospital, Brooklyn, NY 11215 Ph: (718) 780-3279 |
News Archive
The new platform uses cell-free synthetic biology to test for 17 contaminants, including lead, copper, pharmaceuticals and cosmetics.
The Economist examines how "the past decade has seen changes in how vaccines are developed, financed and delivered - solving, at least partially, the conundrum of the vaccine market: poor regions have ample demand for vaccines but little ability to pay for them. As a result, immunisation rates in the poor world have soared."
A trial of beta-interferon-1a in inclusion-body myositis (IBM) has failed to find benefit from the drug in this disease. Beta-interferons counteract some of the activities of the immune system, which some experts believe is misguided in IBM.
A natural products chemistry company has licensed the rights for a promising botanical compound from the University of Mississippi and the Agricultural Research Service, which is the principal intramural scientific research agency of the U.S. Department of Agriculture.
The drug, mitomycin C (MMC), is a well-known anticancer treatment used mainly against solid tumours in the bladder and lower bowel. It is activated by enzymes naturally found in the human body, but its use is limited by severe side effects at higher doses.
› Verified 7 days ago
Stephanie Joseph, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 506 6th St, Ny Methodist Hospital, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Nikia S Nelson, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 506 6th Street, Ny Methodist Hospital, Brooklyn, NY 11215 Phone: 718-780-3279 Fax: 718-780-3281 | |
Mark Lieberman, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4802 10th Ave, Brooklyn, NY 11219 Phone: 718-283-8816 | |
Marina Hanukoff, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 506 6th Street, Ny Methodist Hospital, Brooklyn, NY 11215 Phone: 718-780-3279 | |
Ms. Margaret Mary Gill, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Poly Pl, Brooklyn, NY 11209 Phone: 718-439-4163 | |
Ms. Rita M Riley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 150 55th Street, Brooklyn, NY 11220 Phone: 718-630-7452 Fax: 718-630-6322 | |
Ronell S Kirkley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3279 |